RxDoctor Payments Data

Bill Park

Optometrist · North Aurora, ILNPI 1912902115

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,391 and has fallen 55.6% since, to $618 in 2025. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,392in general payments, 2019–2025

Across 165 payments — averaging $32.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$1K
  • Alcon$919
  • Coopervision Inc.$905
  • Oyster Point Pharma, Inc.$584
  • Bausch & Lomb Americas Inc.$475
  • Glaukos Corporation$280
  • plus $1K from 12 others

What the payments were for

  • Speaking & faculty fees$2565%
  • Food & beverage$5,13695%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,392 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois →

Medicare billing

Part B allowed, 2024
$5,867
Medicare patients
50
Services billed
869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RocklatanNetarsudil Mesylat/Latanoprost11$3,657
Latanoprost101$602
Timolol Maleate12$286
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$179
Dorzolamide Hcl13$50

Paid to pharmacies, not to this prescriber.

Other optometrist in North Aurora

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →